eli lilly oral glp 1 Gets Speedy FDA Nod for GLP-1 Drug, a Competitor to New Novo Nordisk Pill Lilly's oral GLP-1 orforglipron consistent

Saenger AK, Nguyen TV, Vockley J, Stankovich MT

A challenge for GeneDx could come, Peterson added, if the company winds down more of its current menu of tests during the fourth quarter, especially in hereditary cancer testing, which accounts for about $16 million in revenues: Any exit/wind-down could have an impact on 25 revenues. GeneDx has retired about 70% of its testing menu over the past year as it pivoted its operations toward offering diagnostic tests based on whole exome sequencing and whole genome sequencing, with emphasis on enabling diagnosis of rare diseases in children

First, an enzyme called alcohol dehydrogenase converts the alcohol into a substance called acetaldehyde

Similar to SOD1, SOD2 expression is lower in lung tissue compared to other major organs